neoplasm
• tumors are classified as neuroblastoma, stroma-poor, poorly differentiated or differentiating
(J:228124)
• tumor onset occurs later than in mice carrying the Alktm2.1Ics allele
(J:228124)
• abdominal tumors are median, perivascular and locally invasive without evidence of macroscopic tumor spread to other organs
(J:228124)
• tumors at 2 or 3 locations (abdominal/thoracic/cervical) are seen in 70% of mice
(J:228124)
• mice treated with vandetanib, a kinase inhibitor, or crizotinib, show a reduction in abdominal tumor weight
(J:228124)
|
mortality/aging
• mice begin to die around 100 days of age, with 70% survival at 200-300 days of age
|
nervous system
• tumors are classified as neuroblastoma, stroma-poor, poorly differentiated or differentiating
(J:228124)
• tumor onset occurs later than in mice carrying the Alktm2.1Ics allele
(J:228124)
• abdominal tumors are median, perivascular and locally invasive without evidence of macroscopic tumor spread to other organs
(J:228124)
• tumors at 2 or 3 locations (abdominal/thoracic/cervical) are seen in 70% of mice
(J:228124)
• mice treated with vandetanib, a kinase inhibitor, or crizotinib, show a reduction in abdominal tumor weight
(J:228124)
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
neuroblastoma | DOID:769 | J:228124 , J:261033 |